Improved sensitivity to insulin in obese subjects following weight loss is accompanied by reduced protein-tyrosine phosphatases in adipose tissue

Faiyaz Ahmad, Robert Considine, Thomas L. Bauer, Joanna P. Ohannesian, Cheryl C. Marco, Barry J. Goldstein

Research output: Contribution to journalArticle

108 Citations (Scopus)

Abstract

Insulin resistance in adipose tissue in human obesity is associated with increased protein-tyrosine phosphatase (PTPase) activity and elevated levels of the PTPases leukocyte common antigen-related PTPase (LAR) and PTP1B. To determine whether the improved insulin sensitivity associated with weight loss in obese subjects is accompanied by reversible changes in PTPases, we obtained subcutaneous adipose tissue from seven obese subjects (mean body mass index [BMI], 40.4 kg/m2) before and after a loss of 10% of body weight and again after a 4-week maintenance period. Weight loss was accompanied by an 18.5% decrease in overall adipose tissue PTPase activity (P = .015) that was further reduced to 22.3% of the control value (P = .005) at the end of the maintenance period. By immunoblot analysis, the abundance of LAR was decreased by 21% (P = .04) and abundance of PTP1B was decreased by 40% (P <.004) after the initial weight loss, and the decreases persisted during the maintenance period. Enhanced insulin sensitivity following weight loss, evident from a 26% decrease in fasting insulin levels (P <05), was also closely correlated with the reduction in the abundance of both LAR (R2 = .80, P <.01) and PTP1B (R2 = .64, P = .03). These results support the hypothesis that LAR and PTP1B may be reversibly involved in the pathogenesis of insulin resistance, and may be therapeutic targets in insulin-resistant states.

Original languageEnglish (US)
Pages (from-to)1140-1145
Number of pages6
JournalMetabolism: Clinical and Experimental
Volume46
Issue number10
DOIs
StatePublished - 1997
Externally publishedYes

Fingerprint

Protein Tyrosine Phosphatases
Insulin Resistance
Adipose Tissue
Weight Loss
Maintenance
Insulin
CD45 Antigens
Subcutaneous Fat
Fasting
Body Mass Index
Obesity
Body Weight
Therapeutics

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Improved sensitivity to insulin in obese subjects following weight loss is accompanied by reduced protein-tyrosine phosphatases in adipose tissue. / Ahmad, Faiyaz; Considine, Robert; Bauer, Thomas L.; Ohannesian, Joanna P.; Marco, Cheryl C.; Goldstein, Barry J.

In: Metabolism: Clinical and Experimental, Vol. 46, No. 10, 1997, p. 1140-1145.

Research output: Contribution to journalArticle

Ahmad, Faiyaz ; Considine, Robert ; Bauer, Thomas L. ; Ohannesian, Joanna P. ; Marco, Cheryl C. ; Goldstein, Barry J. / Improved sensitivity to insulin in obese subjects following weight loss is accompanied by reduced protein-tyrosine phosphatases in adipose tissue. In: Metabolism: Clinical and Experimental. 1997 ; Vol. 46, No. 10. pp. 1140-1145.
@article{4950fbe0ffef4eadb3730f6708f05f51,
title = "Improved sensitivity to insulin in obese subjects following weight loss is accompanied by reduced protein-tyrosine phosphatases in adipose tissue",
abstract = "Insulin resistance in adipose tissue in human obesity is associated with increased protein-tyrosine phosphatase (PTPase) activity and elevated levels of the PTPases leukocyte common antigen-related PTPase (LAR) and PTP1B. To determine whether the improved insulin sensitivity associated with weight loss in obese subjects is accompanied by reversible changes in PTPases, we obtained subcutaneous adipose tissue from seven obese subjects (mean body mass index [BMI], 40.4 kg/m2) before and after a loss of 10{\%} of body weight and again after a 4-week maintenance period. Weight loss was accompanied by an 18.5{\%} decrease in overall adipose tissue PTPase activity (P = .015) that was further reduced to 22.3{\%} of the control value (P = .005) at the end of the maintenance period. By immunoblot analysis, the abundance of LAR was decreased by 21{\%} (P = .04) and abundance of PTP1B was decreased by 40{\%} (P <.004) after the initial weight loss, and the decreases persisted during the maintenance period. Enhanced insulin sensitivity following weight loss, evident from a 26{\%} decrease in fasting insulin levels (P <05), was also closely correlated with the reduction in the abundance of both LAR (R2 = .80, P <.01) and PTP1B (R2 = .64, P = .03). These results support the hypothesis that LAR and PTP1B may be reversibly involved in the pathogenesis of insulin resistance, and may be therapeutic targets in insulin-resistant states.",
author = "Faiyaz Ahmad and Robert Considine and Bauer, {Thomas L.} and Ohannesian, {Joanna P.} and Marco, {Cheryl C.} and Goldstein, {Barry J.}",
year = "1997",
doi = "10.1016/S0026-0495(97)90206-7",
language = "English (US)",
volume = "46",
pages = "1140--1145",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "10",

}

TY - JOUR

T1 - Improved sensitivity to insulin in obese subjects following weight loss is accompanied by reduced protein-tyrosine phosphatases in adipose tissue

AU - Ahmad, Faiyaz

AU - Considine, Robert

AU - Bauer, Thomas L.

AU - Ohannesian, Joanna P.

AU - Marco, Cheryl C.

AU - Goldstein, Barry J.

PY - 1997

Y1 - 1997

N2 - Insulin resistance in adipose tissue in human obesity is associated with increased protein-tyrosine phosphatase (PTPase) activity and elevated levels of the PTPases leukocyte common antigen-related PTPase (LAR) and PTP1B. To determine whether the improved insulin sensitivity associated with weight loss in obese subjects is accompanied by reversible changes in PTPases, we obtained subcutaneous adipose tissue from seven obese subjects (mean body mass index [BMI], 40.4 kg/m2) before and after a loss of 10% of body weight and again after a 4-week maintenance period. Weight loss was accompanied by an 18.5% decrease in overall adipose tissue PTPase activity (P = .015) that was further reduced to 22.3% of the control value (P = .005) at the end of the maintenance period. By immunoblot analysis, the abundance of LAR was decreased by 21% (P = .04) and abundance of PTP1B was decreased by 40% (P <.004) after the initial weight loss, and the decreases persisted during the maintenance period. Enhanced insulin sensitivity following weight loss, evident from a 26% decrease in fasting insulin levels (P <05), was also closely correlated with the reduction in the abundance of both LAR (R2 = .80, P <.01) and PTP1B (R2 = .64, P = .03). These results support the hypothesis that LAR and PTP1B may be reversibly involved in the pathogenesis of insulin resistance, and may be therapeutic targets in insulin-resistant states.

AB - Insulin resistance in adipose tissue in human obesity is associated with increased protein-tyrosine phosphatase (PTPase) activity and elevated levels of the PTPases leukocyte common antigen-related PTPase (LAR) and PTP1B. To determine whether the improved insulin sensitivity associated with weight loss in obese subjects is accompanied by reversible changes in PTPases, we obtained subcutaneous adipose tissue from seven obese subjects (mean body mass index [BMI], 40.4 kg/m2) before and after a loss of 10% of body weight and again after a 4-week maintenance period. Weight loss was accompanied by an 18.5% decrease in overall adipose tissue PTPase activity (P = .015) that was further reduced to 22.3% of the control value (P = .005) at the end of the maintenance period. By immunoblot analysis, the abundance of LAR was decreased by 21% (P = .04) and abundance of PTP1B was decreased by 40% (P <.004) after the initial weight loss, and the decreases persisted during the maintenance period. Enhanced insulin sensitivity following weight loss, evident from a 26% decrease in fasting insulin levels (P <05), was also closely correlated with the reduction in the abundance of both LAR (R2 = .80, P <.01) and PTP1B (R2 = .64, P = .03). These results support the hypothesis that LAR and PTP1B may be reversibly involved in the pathogenesis of insulin resistance, and may be therapeutic targets in insulin-resistant states.

UR - http://www.scopus.com/inward/record.url?scp=0030821972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030821972&partnerID=8YFLogxK

U2 - 10.1016/S0026-0495(97)90206-7

DO - 10.1016/S0026-0495(97)90206-7

M3 - Article

VL - 46

SP - 1140

EP - 1145

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 10

ER -